Nordion (NYSE:NDZ) said it agreed to a $11.75-per-share buyout offer from private equity-backed Sterigenics.
The $727 million valuation represents a 12% premium on Nordion’s closing price March 27, the day before the deal was announced.
The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Cantel Medical (NYSE:CMN) acquired Sterilator Co. for an undisclosed sum through its Crosstex subsidiary, the companies announced this month.
Sterilator manufactures biological indicators and supplies for sterility assurance products. Cantel Hauppauge, N.Y.-based Crosstex focuses on sterility assurance products and was bought out by Cantel in 2005.
Hospitals in Denmark lifted a hiatus on use of Intuitive Surgical‘s (NSDQ:ISRG) da Vinci robot surgery system after an external investigation resolved sterilization concerns, according to the Danish Health & Medicines Authority.
Steris Corp. (NYSE:STE) landed special 510(k) clearance to modify its System 1E sterilizers, the replacement systems for the troubled System 1 devices that were the center of a 2-year row with the FDA.
The Mentor, Ohio-based device maker won the FDA’s approval to update existing SS1E devices in the field with modified software, which will also be applied to all new shipments, effective immediately.
The FDA slapped Midmark Corp. with a "significant" warning letter after an inspection of its Versailles, Ohio, headquarters last year.
The laundry list of violations from the watchdog agency focused primarily on manufacturing procedures and record-keeping issues related to the company’s steam sterilizer systems.
In one violation, deemed "significant" by the FDA, the health care device maker company failed to file a report after it realized the M11 steam sterilizer door could blow open during use.
Steris Corp. (NYSE:STE) customers have an extra 6 months from the FDA to transition from the company’s recalled System 1 sterilization device.
The med-tech maker will support current System 1 devices until August 2, 2012 but only in companies that provide a certificate of transition identifying the proposed installation date of replacement technology, according to an SEC filing.
Sterilization and decontamination technology firm Steris Corp. (NYSE:STE) opened a new European headquarters in Bordeaux, France.
In the 85,000 square-foot facility, Steris combined marketing, manufacturing, sales, costumer service and research & development.
The Food & Drug Administration gave Steris Corp. (NYSE:STE) customers an additional six months to transition from the company’s recalled System 1 sterilization device.
The agency gave the Mentor, Ohio-based company’s customers until Feb. 2, 2012 to make the change to an alternate processing system, according to a filing with the Securities & Exchange Commission.